Molecular basis of mitogen-activated protein kinase ERK2 activation by its upstream kinase MEK1

von Velsen, J., Juyoux, P., Piasentin, N., Fisher, H., Lapouge, K., Vadas, O., Gervasio, F. L., Bowler, M. W.

10.64898/2026.01.19.700303 · was preprinted

discovery

Surfaced because: matches the platform's topic region.

relevance 0.34 openness 0.00 novelty 0.17

Abstract

The RAS-RAF-MEK-ERK mitogen-activated protein kinase (MAPK) pathway relays extracellular signals into a cellular response and its dysregulation leads to many pathologies, particularly cancer. Much is known about the individual components of the pathway, however, details of their interactions and how specificity is maintained is still poorly understood. Here, we determined cryo-EM structures of the MAP2K MEK1 activating its substrate MAPK ERK2, the final event in the cascade. We define the molecular details of specificity and activation of ERK2 and examine the mechanism of substrate recognition using solution techniques and molecular dynamics. Binding of the substrate MAPK leads to release of the MAP2K catalytic machinery, a mechanism enhanced in many gain of function disease mutations. Further, we observe that ERK2 release is not required for nucleotide exchange, suggesting how a processive mechanism could proceed. Our data advance the understanding of MAPK signalling specificity and provide a starting point for drug development.

Lifecycle

biorxiv v3 2026-10-27 source ↗

Discussion

No qualifying discussion yet.